skip to Main Content

Coronavirus, let testing start to produce the vaccine

Il Tempo

The Italian Company Advent will produce the first 1000 doses

The vaccine for the novel coronavirus is going to be manufactured in Pomezia, Italy. ADVENT Srl., the GMP-certified Contract Development and Manufacturing Organization of IRBM Group, and Jenner Institute of the Oxford University have already started the procedures for the clinical trials.
The Jenner Institute produced a vaccine against MERS with remarkable success, and is going to use the same technology for the novel coronavirus. The vaccine is produced thanks to a safe version of an adenovirus. The adenovirus has been modified so that it cannot reproduce within the body, but it is able to trigger a process that stops the coronavirus from causing an infection.
Dr. Piero Di Lorenzo, President and CEO of IRBM, CEO of Advent and CNCCS, expresses his enthusiasm:
“We are thrilled to be working with the Jenner Institute on this critical project […].Once again IRBM Group is at the forefront of R&D […]”

Article by Massimiliano Gobbi published on Il Tempo09/02/2020

Download pdf
Back To Top